George Church is a distinguished Professor at Harvard Medical School since 1986, specializing in research and teaching. As a prominent figure in biotechnology, Church co-founded several companies including Eugit Therapeutics, Colossal Biosciences, Dyno Therapeutics, ARRIVED AI, eGenesis, Inc., and Editas Medicine, contributing to various fields such as veterinary reproductive technologies and gene editing. Church has also served as an advisor for Genome Compiler Corp. and Genia Corp., focusing on nanopore DNA sequencing. Education includes dual PhD degrees in Biochemistry and Molecular Biology from Harvard University, along with a Bachelor's degree in Chemistry and Zoology from Duke University.
Links